# Daclatasvir

## Daklinza 60mg

#### 藥委會臨採

| 藥品代碼       | ODAK                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:---------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Chronic hepatitis C: Treatment of chronic hepatitis C virus (HCV) genotype 1 or genotype 3 infection in combination with sofosbuvir， with or without ribavirin                                                                                                                                                                                                                                                                            |
| 用法用量       | Not indicated as monotherapy. The American Association for the Study of Liver Diseases/Infectious Diseases Society of America guidelines for testing， managing， and treating hepatitis C no longer include daclatasvir as a component of recommended treatment regimens for hepatitis C virus infection (AASLD/IDSA 2020). (仿單) 60 mg orally once daily with or without food in combination with other agents for chronic hepatitis C. |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 禁忌           | Concurrent use of strong CYP3A inducers (eg， carbamazepine， phenytoin， rifampin， St John's wort). When used in combination with other agents (eg， ribavirin)， the contraindications to those agents also apply (refer to respective labeling information).                                                                                                                                                                           |
| 副作用         | >10%: Central nervous system: Fatigue (14% to 15%)， headache (12% to 14%) Gastrointestinal: Nausea (8% to 15%) Hematologic & Oncologic: Anemia (20%) 1~10% Central nervous system: Drowsiness (5%)， insomnia (3%) Dermatologic: Skin rash (8%) Gastrointestinal: Diarrhea (3% to 5%)， increased serum lipase (>3x ULN， transient)                                                                                                      |
| 孕期用藥建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                     |
| 哺乳期用藥建議 | No (Limited) Human Data – Potential Toxicity(Mother) 無(很少)資料 – 避免使用(母體)                                                                                                                                                                                                                                                                                                                                                         |

